Briefing by Chief of Nuclear, Biological and Chemical Protection Troops of the

Armed Forces of the Russian Federation

The Russian Ministry of Defence continues to analyze documents revealing the

military-biological activities of the Pentagon in Ukraine.
The incoming materials allow us to trace the pattern of interaction between US
government agencies and Ukrainian bio-objects. The involvement of entities close to the
current US leadership, notably the Rosemont Seneca investment fund run by Hunter
Biden, is noticeable in the funding of these activities. The Fund has significant financial
resources of at least $2.4 billion. The foundation is closely linked to key contractors of
the US military department, including Metabiota, which, along with Black and Veach,
is a major supplier of equipment to the Pentagon's bio-labs around the world.
The scale of the program is impressive. The US Agency for International Development,
the George Soros Foundation and the Center for Disease Control and Prevention are
directly involved, in addition to the military department. Scientific supervision is
provided by leading research organisations, including the Los Alamos National
Laboratory, which is developing nuclear weapons as part of the Manhattan Project.
All these activities are carried out under the full control of the Pentagon.
Please note - the registration card which confirms that it was 30 Ukrainian laboratories,
located in 14 settlements, that were involved in full-scale military-biological activities
in Ukraine.
The document was signed by Viktor Polishchuk, Deputy State Secretary of the
Ukrainian Cabinet of Ministers. The legal basis for its signing was the Agreement on
Cooperation to Prevent the Spread of Technologies, Pathogens and Information that
could be used for the development of biological weapons.
The registration card identifies the customer of the work, the US Defense Threat
Reduction Agency, as well as a list of biobjects.
As we have previously reported, the funding for 2018-2020 alone was around $32
million. The text of the document states that the United States, its personnel and
contractors are exempt from the obligation to pay taxes or other similar fees that are
levied in Ukraine.
The Ministry of Defence has disclosed and summarised the flow of biomaterials.
Funding for military-biological activities has enabled the US and its allies to export at
least 16,000 bioassays outside Ukraine.
Thus, under the UP-8 project in Lvov, Kharkov, Odessa and Kiev, blood samples were
taken from 4,000 servicemen for antibodies to hantaviruses and from 400 for antibodies
to the Congo-Crimean fever virus.
This large-scale screening of the natural immunity of the population was probably
carried out in order to select the biological agents most dangerous to the population of a
particular region.
Document review reveals that not only human tissue and serum samples, but also
dangerous pathogens and their transporters were exported. Thus, more than 10,000
samples were sent to Lugar Centre in Georgia. Other recipients include: reference
laboratories in the UK, the Loeffler Institute in Germany.
All this creates risks for the transfer abroad of sensitive genetic information, as well as
threats to biological security not only for Ukraine, but also for the regions where the
samples were transferred.
One of the US customers' priorities is the anthrax pathogen, which is highly susceptible
and persistent in the environment.
The slide shows documents from the UP-2 project, one of the tasks of which was to
identify dead animal burial sites, taking soil samples from anthrax animal burial sites.
The interest of US military biologists in studying insect vectors in animal burial sites is
also not accidental. Apparently, they analysed the results of an outbreak of anthrax
disease in Yamal in 2016, during which cases of vector-borne transmission through flies
and gadflies were recorded.
Given that the situation with anthrax in Ukraine remains positive, it raises the question
of the need for the Pentagon's research and its true purpose.
We know of examples where the US military departments work with anthrax has ended
in biosecurity emergencies.
Between 2005 and 2015, viable anthrax spores were sent from the US Army's Dugway
proving ground to 194 recipients in ten countries.
The current situation with the shipment of pathogenic biomaterials from Ukraine to
European countries could result in loss of life and create a hotbed of epidemiological
instability on a scale comparable to the COVID-19 pandemic.
We continue to share information on research involving Ukrainian military personnel.
We would like to point out that such work is prohibited within the US and is carried out
by the military department outside the US.
Earlier mention was made of the UP-8 research, which involved more than 4,000
people. According to figures published in the Bulgarian media, some 20 Ukrainian
soldiers were killed in experiments in the Kharkov laboratory alone and another 200
were hospitalised.
The documents received confirm the attempt to test previously untested medicines on
them. This is the Deep Drug screening system for unlicensed pharmaceuticals in the
United States and Canada.
What makes the US sponsors particularly cynical is that the developer, Scymount,
offered to purchase the system in question on a commercial basis, despite the fact that
Ukrainian Ministry of Defence officials were engaged as volunteers.
Such unacceptable approaches, with the tacit approval of the US administration, are the
norm for big pharma companies. For example, the US Naval Medical Centre in Jakarta
was shut down by Indonesian authorities in 2010 because of numerous irregularities.
The Americans conducted work at the site outside the agreed research programme,
collected biological samples and refused to inform the Indonesian government of their
findings. The materials they obtained were used on behalf of the Pentagon-affiliated
pharmaceutical company Gilead, which conducts trials of its drugs, including in
Ukraine and Georgia.
We would like to draw attention that the number of biological laboratories in the USA is
not comparable with other countries. According to the Chinese Foreign Ministry, they
control 336 laboratories in 30 states outside national jurisdiction.
We believe that in the context of the incoming information, clarification should be
sought from Washington regarding the true objectives of the US biolaboratories as part
of the international investigation.